The Health Department has confirmed that the Albanese Government's commitment to reimburse the states for procuring Norgine's eflornithine (DFMO) for high-risk neuroblastoma is not covered by any agreement with the company. …
No agreement required to deliver early patient access to neuroblastoma treatment
July 19, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The 'Week in Review' Podcast - 18 October
October 18, 2024 - - Podcast -
New research uncovers Australian women are often reluctant to openly talk about menopause
October 18, 2024 - - Latest News -
The danger of this outlier is reflected in the disconnect with another policy process
October 18, 2024 - - Latest News -
Pharmac seeking bids from suppliers of COVID-19 vaccines
October 17, 2024 - - Latest News -
Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities
October 17, 2024 - - Latest News -
This has happened before and the response should be the same. No.
October 17, 2024 - - Latest News -
Vitalis and Servita partner to lead healthcare digital transformation in Queensland
October 17, 2024 - - Latest News